[When is laryngectomy indicated in hypopharyngeal carcinoma?].

B Dubs, G Clavadetscher, S Schmid
{"title":"[When is laryngectomy indicated in hypopharyngeal carcinoma?].","authors":"B Dubs,&nbsp;G Clavadetscher,&nbsp;S Schmid","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>We studied the histories of 121 patients with hypopharyngeal carcinoma treated at our clinic from 1990-1998. From 1990-1993 all patients with curable hypopharyngeal carcinoma were treated by surgery. Radiotherapy was used for those in whom surgery was impossible or who refused laryngectomy. In 1994 we changed our therapy and only patients in whom the voice could be preserved were treated surgically. All others received radiotherapy as primary treatment. The goal of this study was to ascertain whether and how this shift in therapy was influenced by T and N stage.</p><p><strong>Methods: </strong>From 1990-1993, 57 patients with hypopharyngeal carcinoma were registered at our clinic. Surgery was performed in 32, 16 received radiotherapy and 9 only palliative treatment. During this time there was no difference in diseased specific survival between the radiotherapy and surgical groups. Therapy was therefore changed in 1994 to preserve voice function. From 1994-1998, 64 patients were diagnosed. Only 10 were treated surgically. 40 received radiotherapy and 14 no curative therapy. Age, N and T stage were comparable in both groups. To show differences we performed Kaplan Meier survival rates for both groups and for the N and T stage of patients undergoing surgery or radiotherapy respectively.</p><p><strong>Results: </strong>3-year survival was 68% in patients treated from 1990-1993 and 38% from 1994-1998. The difference was statistically significant (p-value 0.02). Survival for nodal stages 0 and 1 was much better in patients undergoing surgery than those receiving radiotherapy. Multivariant analysis was highly significant. T-category showed no tendency for either treatment modality.</p><p><strong>Discussion: </strong>After a switch in the treatment of hypopharyngeal carcinoma in 1994 there was a significant change in survival. For patients with nodal stage 0 and 1 surgery brought much better survival. We conclude that surgery should be the primary treatment for all patients in these small nodal stages, even if total laryngectomy is necessary.</p>","PeriodicalId":76532,"journal":{"name":"Schweizerische medizinische Wochenschrift. Supplementum","volume":"116 ","pages":"22S-26S"},"PeriodicalIF":0.0000,"publicationDate":"2000-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Schweizerische medizinische Wochenschrift. Supplementum","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: We studied the histories of 121 patients with hypopharyngeal carcinoma treated at our clinic from 1990-1998. From 1990-1993 all patients with curable hypopharyngeal carcinoma were treated by surgery. Radiotherapy was used for those in whom surgery was impossible or who refused laryngectomy. In 1994 we changed our therapy and only patients in whom the voice could be preserved were treated surgically. All others received radiotherapy as primary treatment. The goal of this study was to ascertain whether and how this shift in therapy was influenced by T and N stage.

Methods: From 1990-1993, 57 patients with hypopharyngeal carcinoma were registered at our clinic. Surgery was performed in 32, 16 received radiotherapy and 9 only palliative treatment. During this time there was no difference in diseased specific survival between the radiotherapy and surgical groups. Therapy was therefore changed in 1994 to preserve voice function. From 1994-1998, 64 patients were diagnosed. Only 10 were treated surgically. 40 received radiotherapy and 14 no curative therapy. Age, N and T stage were comparable in both groups. To show differences we performed Kaplan Meier survival rates for both groups and for the N and T stage of patients undergoing surgery or radiotherapy respectively.

Results: 3-year survival was 68% in patients treated from 1990-1993 and 38% from 1994-1998. The difference was statistically significant (p-value 0.02). Survival for nodal stages 0 and 1 was much better in patients undergoing surgery than those receiving radiotherapy. Multivariant analysis was highly significant. T-category showed no tendency for either treatment modality.

Discussion: After a switch in the treatment of hypopharyngeal carcinoma in 1994 there was a significant change in survival. For patients with nodal stage 0 and 1 surgery brought much better survival. We conclude that surgery should be the primary treatment for all patients in these small nodal stages, even if total laryngectomy is necessary.

下咽癌何时需要喉切除术?
简介:我们研究了1990-1998年在我诊所治疗的121例下咽癌患者的病史。1990 ~ 1993年所有可治愈的下咽癌患者均行手术治疗。放疗用于无法手术或拒绝喉切除术的患者。1994年,我们改变了治疗方法,只有那些能保留声音的病人才接受手术治疗。其余均以放射治疗为主。本研究的目的是确定这种治疗的转变是否以及如何受到T和N期的影响。方法:对我院1990 ~ 1993年收治的下咽癌患者57例进行回顾性分析。手术32例,放疗16例,姑息治疗9例。在此期间,放疗组和手术组之间的病变特异性生存率没有差异。因此,1994年改变了治疗方法,以保持语音功能。1994-1998年共确诊64例。只有10人接受了手术治疗。40例放疗,14例无疗效。两组患者年龄、N、T分期具有可比性。为了显示差异,我们分别对两组和接受手术或放疗的N期和T期患者进行Kaplan Meier生存率。结果:1990-1993年治疗的3年生存率为68%,1994-1998年治疗的3年生存率为38%。差异有统计学意义(p值为0.02)。手术患者的0期和1期生存率比放疗患者高得多。多变量分析具有高度显著性。t型没有显示两种治疗方式的倾向。讨论:1994年下咽癌治疗的转变后,生存率发生了显著变化。对于0期和1期淋巴结患者,手术带来了更好的生存率。我们的结论是,手术应该是所有这些小结节期患者的主要治疗方法,即使需要全喉切除术。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信